Elocta

efmoroctocog alfa · Swedish Orphan Biovitrum (Sobi)

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Elocta, covering 2024-09-19 to 2026-07-16. Get the full timeline:

Most recent: EMA Authorised: Elocta (efmoroctocog alfa) — Swedish Orphan Biovitrum AB (publ)